Clinical Trial Spotlight: Asthma Research Study
Researchers are conducting a study to test the safety of a type of asthma medication called formoterol, a component of Symbicort, when it is taken in combination with inhaled corticosteroids to find out if the addition of an inhaled corticosteroid, such as budesonide, reduces the increased risk of asthma-related hospitalizations and death from formoterol.
They are looking for adolescents and adults, aged 12 years and older, who have been diagnosed with asthma. Participants will be compensated for study-related time and travel.
For more information, contact the research coordinator at 513-558-5795 or 513-558-0924.
Tags
Related Stories
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.
Funding expands UC research into weight gain side effects of bipolar medication
August 26, 2026
University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.
One in four NFL players had CTE at death
August 25, 2026
Forbes cites research on concussions and football helmets by the University of Cincinnati in a report that found one in four NFL players had brain damage at death.